rss
Arch Dis Child Fetal Neonatal Ed 2003;88:F444 doi:10.1136/fn.88.5.F444
  • LETTER

Late anaemia in Rh haemolytic disease

  1. F Ovalý
  1. Istanbul Medical Faculty, Istanbul University, Turkey; fovali@yahoo.com

      As it is clearly stated in the review by Gottstein and Cooke,1 we consider it unethical to withhold or delay high dose intravenous immunglobulin (IVIG) treatment in infants with haemolytic disease of the newborn. Since the study we did in 1995,2 we have treated 129 patients with Coomb’s positive haemolytic disease of the newborn, with the same method and had to …

      [Full text of this article]

      This Article

      1. Extract
      2. Full text
      3. PDF

      Responses

      1. Submit a response
      2. No responses published

      Register for free content


      Free trial
      Individuals may register for a free 60 day online trial to all content.

      Free archive
      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.